Geographic Variation in Opioid and Heroin Involved Drug Poisoning Mortality Rates

American Journal of Preventive Medicine

Volumn 53, Issue 6, 2017, Pages 745-753

  Ruhm, Christopher J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; OPIATE; NARCOTIC ANALGESIC AGENT;

ALABAMA; ARIZONA; ARKANSAS; ARTICLE; CALIFORNIA; COLORADO; CONNECTICUT; DELAWARE; DISTRICT OF COLUMBIA; DRUG FATALITY; DRUG INTOXICATION; DRUG OVERDOSE; FEMALE; FLORIDA; GEOGRAPHY; HAWAII; HUMAN; INDIANA; IOWA; KANSAS; KENTUCKY; LOUISIANA; MAINE; MAJOR CLINICAL STUDY; MALE; MARYLAND; MASSACHUSETTS; MICHIGAN; MINNESOTA; MISSISSIPPI; MISSOURI; MONTANA; MORTALITY RATE; NEBRASKA; NEVADA; NEW HAMPSHIRE; NEW JERSEY; NEW MEXICO; NEW YORK; NORTH CAROLINA; NORTH DAKOTA; OHIO; OKLAHOMA; OREGON; PENNSYLVANIA; RHODE ISLAND; SOUTH CAROLINA; SOUTH DAKOTA; TENNESSEE; TEXAS; UTAH; VERMONT; VIRGINIA; WASHINGTON; WEST VIRGINIA; WISCONSIN; WYOMING; ADULT; AGED; DEATH CERTIFICATE; MIDDLE AGED; MORTALITY; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; DEATH CERTIFICATES; DRUG OVERDOSE; FEMALE; HEROIN; HUMANS; MALE; MIDDLE AGED; UNITED STATES;

EID: 85026829710     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2017.06.009     Document Type: Article

References (38)

1. Rudd, R.A., Aleshire, N., Zibbell, J.E., Gladden, R.M., Increase in drug and opioid overdose deaths – United States, 2000-2014. MMWR Morb Mortal Wkly Rep 64:50–51 (2016), 1378–1382, 10.15585/mmwr.mm6450a3.
2. Warner, M., Chen, L.H., Makuc, D.M., Anderson, R.N., Miniño, A.M., Drug poisoning deaths in the United States, 1980–2008. NCHS Data Brief, no 81. 2011, National Center for Health Statistics, Hyattsville, MD https://doi.org/10.1073/pnas.1518393112.
3. Case, A., Deaton, A., Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc Natl Acad Sci U S A 112:49 (2015), 15078–15083, 10.1073/pnas.1518393112.
4. CDC. Vital Signs: Overdoses of prescription opioid pain relievers - United States, 1999–2008. MMWR Morb Mortal Wkly Rep 60:43 (2011), 1487–1492.
5. CDC. Vital Signs: Risk for overdose from methadone used for pain relief – United States, 1999-2010. MMWR Morb Mortal Wkly Rep 61:26 (2012), 493–497.
6. Volkow, N.D., Frieden, T.R., Hyde, P.S., Cha, S.S., Medication-assisted therapies – tackling the opioid overdose epidemic. N Engl J Med 370:22 (2014), 2063–2066, 10.1056/NEJMp1402780.
7. Jones, C.M., Logan, J., Gladden, R.M., Bohm, M.K., Vital signs: demographic and substance use trends among heroin users—United States, 2002–2013. MMWR Morb Mortal Wkly Rep 64 (2015), 719–725.
8. Hardesty, C., White House Summit on the Opioid Epidemic. June 19, 2014, Office of National Drug Policy, Washington DC www.whitehouse.gov/blog/2014/06/19/white-house-summit-opioid-epidemic Accessed June 27, 2017.
9. CDC. Opioids drive continued increase in drug overdose deaths, 2013 www.cdc.gov/media/releases/2013/p0220_drug_overdose_deaths.html Accessed June 27, 2017.
10. Finklea, K.M., Bagalman, E., Sacco, L.N., Prescription drug monitoring programs. 2013, Library of Congress, Congressional Research Service, Washington, DC www.hsdl.org/?abstract&did=728239 Accessed June 27, 2017.
11. Rannazzisi, J.T., Testimony for “Curbing Prescription Drug Abuse in Medicare”. Hearing before the Committee on Homeland Security and Governmental Affairs, United States Senate, 113th Congress, 2013 www.gpo.gov/fdsys/pkg/CHRG-113shrg82571/pdf/CHRG-113shrg82571.pdf Accessed June 27, 2017.
12. Kirschner, N., Ginsburg, J., Sulmasy, L.S., Health and Public Policy Committee of the American College of Physicians. Prescription drug abuse: executive summary of a policy position paper from the American College of Physicians. Ann Intern Med 160:3 (2014), 198–200, 10.7326/M13-2209.
13. Paulozzi, L.J., Kilbourne, E.M., Desai, H.A., Prescription drug monitoring programs and death rates from drug overdose. Pain Med 12:5 (2011), 747–754, 10.1111/j.1526-4637.2011.01062.x.
14. Gugelmann, H.M., Perrone, J., Can prescription drug monitoring programs help limit opioid abuse?. JAMA 306:20 (2011), 2258–2259, 10.1001/jama.2011.1712.
15. Li, G., Brady, J.E., Lang, B.H., Giglio, J., Wunsch, H., DiMaggio, C., Prescription drug monitoring and drug overdose mortality. Inj Epidemiol 1:1 (2014), 1–8, 10.1186/2197-1714-1-1.
16. Johnson, H., Paulozzi, L., Poruncznik, C., Mack, K., Herter, B., Hal Jonson Consulting, Division of Disease Control and Health Promotion, Florida Department of Health. Decline in drug overdose deaths after state policy changes – Florida, 2010-2012. MMWR Morb Mortal Wkly Rep 63:26 (2014), 569–574.
17. Ruhm, C.J., Drug involvement in fatal overdoses. SSM Popul Health 3 (2017), 219–226, 10.1016/j.ssmph.2017.01.009.
18. Slavova, S., O'Brien, D.B., Creppage, K., et al. Drug overdose deaths: let's get specific. Public Health Rep 130:4 (2015), 339–342, 10.1177/003335491513000411.
19. Vestal, C., Stateline: getting better data on which drugs are killing people. Pew Charitable Trusts, August 19, 2016 www.pewtrusts.org/en/research-and-analysis/blogs/stateline/2016/08/19/getting-better-data-on-which-drugs-are-killing-people Accessed November 1, 2016.
20. Ruhm, C.J., Drug poisoning deaths in the United States, 1999-2012: a statistical adjustment analysis. Popul Health Metr, 14, 2016, 2, 10.1186/s12963-016-0071-7.
21. Rossen, L.M., Khan, D., Warner, M., Trends and geographic patterns in drug-poisoning death rates in the U.S., 1999–2009. Am J Prev Med 45:6 (2013), e19–e25, 10.1016/j.amepre.2013.07.012.
22. Rossen, L.M., Bastian, B., Warner, M., Khan, D., Chong, Y., Drug poisoning mortality: United States, 1999–2014. National Center for Health Statistics, 2016 https://blogs.cdc.gov/nchs-data-visualization/drug-poisoning-mortality/ Accessed November 2, 2016.
23. CDC. Multiple cause of death, 1999–2014. http://wonder.cdc.gov/wonder/help/mcd.html. Accessed June 15, 2016.
24. WHO. International Statistical Classification of Diseases and Related Health Problems, ICD-10, 10th Revised, 2012, WHO, Geneva.
25. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. www.seer.cancer.gov/resources. Accessed August 4, 2016.
26. Warner, M., Paulozzi, L.J., Nolte, K.B., Davis, G.G., Nelson, L.S., State variation in certifying manner of death and drugs involved in drug intoxication deaths. Acad Forensic Pathol 3:2 (2013), 231–237.
27. Webster, L.R., Dasgupta, N., Obtaining adequate data to determine causes of opioid-related overdose deaths. Pain Med 12:Suppl 2 (2011), S86–S92, 10.1111/j.1526-4637.2011.01132.x.
28. Goldberger, B.A., Maxwell, J.C., Campbell, A., Wilford, B.B., Uniform standards and case definitions for classifying opioid-related deaths: recommendations by a SAMHSA Consensus Panel. J Addict Dis 32:3 (2013), 231–243, 10.1080/10550887.2013.824334.
29. Comprehensive Addiction and Recovery Act of 2016, Pub. L. No: 114-198, 130 Stat. 695, 2016 https://www.congress.gov/114/plaws/publ198/PLAW-114publ198.pdf Accessed November 2, 2016.
30. Office of the Press Secretary, The White House. President Obama proposes $1.1 billion in new funding to address the prescription opioid abuse and heroin use epidemic. J Pain Palliat Care Pharmacother 30:2 (2016), 134–137, 10.3109/15360288.2016.1173760.
31. Kindig, D.A., Cheng, E.R., Even as mortality fell in most U.S. counties, female mortality nonetheless rose in 42.8 percent of counties from 1992 to 2006. Health Aff (Millwood) 32:3 (2013), 451–458, 10.1377/hlthaff.2011.0892.
32. Meara, E., Skinner, J., Losing ground at midlife in America. Proc Natl Acad Sci U S A 112:49 (2015), 15006–15007, 10.1073/pnas.1519763112.
33. Meara, E., Horwitz, J.R., Powell, W., et al. State legal restrictions and prescription-opioid use among disabled adults. N Engl J Med 375:1 (2016), 44–53, 10.1056/NEJMsa1514387.
34. Substance Abuse and Health Services Administration. Medicaid Coverage and Financing of Medications to Treat Alcohol and Opioid Disorders. HHS Publication No. SMA-14-4854. 2014, Substance Abuse and Mental Health Services Administration, Rockville, MD.
35. Gelman, A., Hill, J., Data Analysis Using Regression and Multilevel/Hierarchical Models. 2006, Cambridge University Press, New York http://dx.doi.org/10.1017/CBO9780511790942.
36. Hollingsworth, A., Ruhm, C.J., Simon, K., Macroeconomic conditions and opioid abuse. NBER Work Pap Ser, 2017, 23192, 10.3386/w23192.
37. Mertz, K.J., Janssen, J.K., Williams, K.E., Underrepresentation of heroin involvement in unintentional drug overdose deaths in Allegheny County, PA. J Forensic Sciences 59:6 (2014), 1583–1585, 10.1111/1556-4029.12541.
38. Ellis, A.D., McGwin, G., Davis, G.G., Dye, D.W., Identifying cases of heroin toxicity where 6-acetylmorphine (6-AM) is not detected by toxicological analyses. Forensic Sci Med Pathol 12:3 (2016), 243–247, 10.1007/s12024-016-9780-2.